Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
Jie ZhengiD, Valeriia HaberlandiD, Denis A. BairdiD, Venexia M. WalkeriD, Philip HaycockiD, Mark R. Hurle, Alex GutteridgeiD, Pau ErolaiD, Yi LiuiD, Shan LuoiD, Jamie W. RobinsoniD, Tom G. RichardsoniD, James R StaleyiD, Benjamin ElsworthiD, Stephen BurgessiD, Benjamin B. SuniD, John DaneshiD, Heiko RunziD, Joseph MaranvilleiD, Hannah M. MartiniD, James YarmolinskyiD, Charles LauriniD, Michael Vaclav HolmesiD, Jimmy Z. LiuiD, Karol EstradaiD, , Tom R. GauntiD
Abstract
The human proteome is a major source of therapeutic targets. Recent genetic association analyses of the plasma proteome enable systematic evaluation of the causal consequences of variation in plasma protein levels. Here, we estimated the effects of 1002 proteins on 225 phenotypes using two-sample Mendelian randomization (MR) and colocalization. Of 413 associations supported by evidence from MR, 130 (31.5%) were not supported by results of colocalization analyses, suggesting that genetic confounding due to linkage disequilibrium (LD) is widespread in naive phenome-wide association studies of proteins. Combining MR and colocalization evidence in cis-only analyses, we identified 111 putatively causal effects between 65 proteins and 52 disease-related phenotypes (www.epigraphdb.org/pqtl/). Evaluation of data from historic drug development programmes showed that target-indication pairs with MR and colocalization support were more likely to be approved, evidencing the value of our approach in identifying and prioritising potential therapeutic targets.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 811
- FWCI
- 39.54
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteome-by-phenome Mendelian Randomisation detects 38 proteins with causal roles in human diseases and traits
Andrew D. Bretherick, Oriol Canela‐Xandri, … Chris Haley·PLoS GeneticsPeer-reviewed·Jul 6, 2020
- Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets
Chen‐Yang Su, Adriaan van der Graaf, … Satoshi Yoshiji·medRxiv·Oct 17, 2024
- Consequences Of Natural Perturbations In The Human Plasma Proteome
Benjamin B. Sun, Joseph Maranville, … Adam S. Butterworth·NaturePeer-reviewed·May 29, 2018
- Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases
Huiling Zhao, Humaria Rasheed, … Jie Zheng·Cell GenomicsPeer-reviewed·Oct 12, 2022
- Genetic drug target validation using Mendelian randomization
Amand Floriaan Schmidt, Chris Finan, … Aroon Dinesh Hingorani·bioRxiv·Sep 25, 2019
- Proteome-wide Mendelian randomization identifies candidate causal proteins for cardiovascular diseases
Chen Li, Nicolas De Jay, … Erika M. Kvikstad·Advanced GeneticsPeer-reviewed·Mar 10, 2025